By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharmaceuticals Moves To Strengthen Growth With Appointment Of Chief Medical And Chief Scientific Officers 1/27/2015 11:12:23 AM
Ferring Pharmaceuticals Opens New U.S. Operations Center With Plans For Significant Job Growth In New Jersey 12/5/2014 7:05:23 AM
Ferring Pharmaceuticals Release: New Data From A Pooled Analysis Shows Improved Overall Survival For Prostate Cancer Patients Treated With FIRMAGON® (Degarelix) Compared To LHRH Agonists 11/25/2014 10:04:28 AM
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval 10/22/2014 10:50:42 AM
Ferring Pharmaceuticals To Acquire Marketing Rights For DDAVP┬« (desmopressin) Product Portfolio From Sanofi (SAN.PA) 10/22/2014 9:13:16 AM
Ferring Pharmaceuticals Receives FDA Approval For New Cranberry Flavor Of PREPOPIK® (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid) 10/7/2014 8:14:20 AM
Ferring Pharmaceuticals, Roche (RHHBY) Partner Up To Make Personalised Infertility Treatment Possible 6/24/2014 6:39:56 AM
Ferring Pharmaceuticals Launches Guts4life, An Interactive Online Resource For People With Inflammatory Bowel Disease 5/19/2014 8:49:16 AM
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014 9:25:04 AM
Merck & Co., Inc. (MRK), Ferring Pharmaceuticals And The World Health Organization Working Together To Prevent Excessive Bleeding In Women After Childbirth 4/4/2014 8:14:45 AM